Unlicensed and off-label drug use in children: implications for safety.
about
WITHDRAWN: Diclofenac for acute pain in children.Diclofenac for acute pain in childrenDiclofenac for acute pain in childrenViews of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature reviewAdverse drug reactions of spontaneous reports in Shanghai pediatric populationCore requirements for successful data linkage: an example of a triangulation method'The more you link, the more you risk …' - a focus group study exploring views about data linkage for pharmacovigilance.Off-label and unlicensed medicines to hospitalised children in Norway.Controversies concerning the diagnosis and treatment of bipolar disorder in children.Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactionsTrends in accessibility to medicines for children in New Zealand: 1998-2002.Linking NHS data for pediatric pharmacovigilance: Results of a Delphi survey.Adverse drug reactions and off-label drug use in paediatric outpatientsAcute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary careOff-label use in Germany - a current appraisal of gynaecologic university departments.Promoting appropriate use of drugs in childrenReported paediatric adverse drug reactions in the UK 2000-2009Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians.Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.Drug use in children: cohort study in three European countries.Federal legislation and the advancement of neonatal drug studiesPrioritising neonatal medicines research: UK Medicines for Children Research Network scoping surveyProspective observational study of adverse drug reactions to diclofenac in childrenThe in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.Drugs and newborn.Evaluating the accuracy of electronic pediatric drug dosing rules.Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.Medication use in children with asthma: not a child size problem.Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.Off-label drug use in pediatric patients.Episodic migraines in children: limited evidence on preventive pharmacological treatments.Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System.Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis.Methodological and ethical aspects of randomized controlled clinical trials in minors with malignant diseases.Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.Monitoring adverse drug reactions in children using community pharmacies: a pilot study.
P2860
Q24186675-404FDCCE-3CA1-4F5D-9028-564E8D643EC3Q24240354-0615371A-56D5-4256-BCB5-240460BC32BFQ24246170-EC81D7F9-8CF0-4B9B-BA11-395F9C33AB7EQ27008494-8CBA003F-07DF-49BC-A10B-7831C5C3F342Q28540105-009D83A7-CC1E-4CD9-9FCD-E83051FB59B3Q28596545-959102BF-A1FA-4BC7-A019-FCF505DC7EACQ30831823-51A0410A-33A8-4915-A440-C60C250045B2Q33578373-6F3BCAE9-452B-485B-8CC7-DE94CB8E5972Q33758856-D12A66D7-2A76-4558-8D78-00D070021FDEQ34976492-08203708-7C64-40D3-8B77-98CAF45DA098Q35681274-89A4AC51-892E-4DAD-B1F6-0D02D3EEF9A9Q35728734-374B88E6-9005-48F4-997C-D4654CFEAC6AQ35804191-CE215126-C8C2-4163-8680-ACFA56130C23Q35827051-407C7875-19C7-4445-89FE-F96AF123B535Q35958959-714879FA-1B49-4FED-8B10-3C7B67D54447Q35975037-B86A2C08-1FEB-4AF4-8FCC-B1A7D462F868Q36017395-B605D6A5-9B2D-4ECA-9942-6A1C63109312Q36024505-A29D932B-5D91-41C6-AA6F-9B9252A08AACQ36153091-DE602EB7-475E-4144-965F-551B3D2AE19CQ36565063-7674DB28-780F-4A70-B4AC-30023BC54926Q36994964-B6184A5C-1A8A-43A1-957F-88228546F827Q37045447-36DB33BF-2AF9-4741-B124-332D94723D6BQ37324844-A2FD830B-756D-4B46-B934-E78B41D314D5Q37399454-CFE60829-B829-4A7D-972D-1DC6D85D36A8Q37521422-AC85D9EA-8179-427D-9E78-4B17B3321DBBQ37635184-E9E264A2-1025-48B6-9149-5F766135D9A2Q37642922-96335A8F-3EA8-47F1-A8B6-BB98588115A4Q37872784-A98429B4-C486-4448-BAB3-402F481F57DFQ37947668-D9BA19B9-1F56-41DF-9505-F3A5D10168D3Q37968148-539C7AD5-9222-497C-AFC3-25BA84404FBDQ37976848-C1E050D4-D0C2-4CD3-824A-C423816E312FQ37999650-D71625A1-6C97-4B7B-A6BC-AC1DE0419750Q38113395-67D5A3CB-1FEF-43C4-AE30-4494016AF84AQ38260525-4C6C9128-00F0-41C4-BA87-86D200058A13Q38594812-D665ABE4-7F2E-4540-90B1-D9E6D04506E0Q38628506-FCC0C35B-202C-4458-A719-6A59D78EF3BBQ39420922-0C227910-4A79-4534-B32E-60366A402ABDQ39753283-E19E387F-B2D5-4437-8C07-A9A509EE3985Q40193019-829273A5-72EE-4A6E-8C9B-D4E96785C52DQ40506499-B1612C90-D0F2-48B2-B09A-B9E9BDCDD472
P2860
Unlicensed and off-label drug use in children: implications for safety.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Unlicensed and off-label drug use in children: implications for safety.
@ast
Unlicensed and off-label drug use in children: implications for safety.
@en
Unlicensed and off-label drug use in children: implications for safety.
@nl
type
label
Unlicensed and off-label drug use in children: implications for safety.
@ast
Unlicensed and off-label drug use in children: implications for safety.
@en
Unlicensed and off-label drug use in children: implications for safety.
@nl
prefLabel
Unlicensed and off-label drug use in children: implications for safety.
@ast
Unlicensed and off-label drug use in children: implications for safety.
@en
Unlicensed and off-label drug use in children: implications for safety.
@nl
P1433
P1476
Unlicensed and off-label drug use in children: implications for safety.
@en
P2093
Imti Choonara
Sharon Conroy
P356
10.2165/00002018-200225010-00001
P577
2002-01-01T00:00:00Z
P6179
1030810498